A patient is prescribed propylthiouracil (PTU). Which mechanism distinguishes PTU from methimazole?
Show answer and explanation
Correct answer: Inhibition of peripheral T4-to-T3 conversion
PTU inhibits both thyroid peroxidase and peripheral T4-to-T3 conversion; methimazole inhibits only the former.
Keep practicing
More Endocrine pharmacotherapy questions
- A patient with type 1 diabetes begins insulin glargine. What is a major benefit of this formulation?
- Which diabetes medication should be avoided in patients with heart failure due to fluid retention?
- A woman with PCOS is prescribed spironolactone. What symptom is this medication intended to treat?
- A patient receiving insulin therapy experiences hypoglycemia with confusion and sweating. Which is the fastest treatment option?
- A patient with hyperthyroidism is treated with radioactive iodine. Which side effect is most likely?
- A diabetic patient is taking acarbose. What is the drug’s primary mechanism?